These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36480397)

  • 1. World Health Organization (WHO) risk level reductions in inpatients with alcohol use disorder and comorbid anxiety disorders.
    Stevenson BL; Anker J; Thuras P; Rinehart L; Kushner MG
    Psychol Addict Behav; 2023 Aug; 37(5):713-722. PubMed ID: 36480397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of Posttreatment Reductions in World Health Organization (WHO) Drinking Risk Levels and Posttreatment Functioning in Older Adults with DSM-5 Alcohol Use Disorder: Secondary Data Analysis of the Elderly Study.
    Mejldal A; Andersen K; Behrendt S; Bilberg R; Bogenschutz M; Braun-Michl B; Bühringer G; Søgaard Nielsen A
    Alcohol Clin Exp Res; 2021 Mar; 45(3):638-649. PubMed ID: 33496964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of Drinking Reductions and Long-term Functioning Among Patients with Alcohol Use Disorder.
    Witkiewitz K; Kranzler HR; Hallgren KA; Hasin DS; Aldridge AP; Zarkin GA; Mann KF; O'Malley SS; Anton RF
    J Gen Intern Med; 2021 Feb; 36(2):404-412. PubMed ID: 33180306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance of World Health Organization Risk Drinking Level Reductions and Posttreatment Functioning Following a Large Alcohol Use Disorder Clinical Trial.
    Witkiewitz K; Falk DE; Litten RZ; Hasin DS; Kranzler HR; Mann KF; O'Malley SS; Anton RF
    Alcohol Clin Exp Res; 2019 May; 43(5):979-987. PubMed ID: 30951210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction in non-abstinent WHO drinking risk levels and depression/anxiety disorders: 3-year follow-up results in the US general population.
    Knox J; Scodes J; Wall M; Witkiewitz K; Kranzler HR; Falk D; Litten R; Mann K; O'Malley SS; Anton R; Hasin DS;
    Drug Alcohol Depend; 2019 Apr; 197():228-235. PubMed ID: 30852375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of abstinence, no heavy drinking days, and a 2-level reduction in World Health Organization drinking levels during treatment for alcohol use disorder in the COMBINE study.
    Wallach JD; Gueorguieva R; Phan H; Witkiewitz K; Wu R; O'Malley SS
    Alcohol Clin Exp Res; 2022 Jul; 46(7):1331-1339. PubMed ID: 35616436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alcoholics Anonymous and other 12-step programs for alcohol use disorder.
    Kelly JF; Humphreys K; Ferri M
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012880. PubMed ID: 32159228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. World Health Organization risk drinking level reductions are associated with improved functioning and are sustained among patients with mild, moderate and severe alcohol dependence in clinical trials in the United States and United Kingdom.
    Witkiewitz K; Heather N; Falk DE; Litten RZ; Hasin DS; Kranzler HR; Mann KF; O'Malley SS; Anton RF
    Addiction; 2020 Sep; 115(9):1668-1680. PubMed ID: 32056311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Validation of Reduced Alcohol Consumption After Treatment for Alcohol Dependence Using the World Health Organization Risk Drinking Levels.
    Witkiewitz K; Hallgren KA; Kranzler HR; Mann KF; Hasin DS; Falk DE; Litten RZ; O'Malley SS; Anton RF
    Alcohol Clin Exp Res; 2017 Jan; 41(1):179-186. PubMed ID: 28019652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reductions in World Health Organization risk drinking level are associated with improvements in sleep problems among individuals with alcohol use disorder.
    Garcia CC; Richards DK; Tuchman FR; Hallgren KA; Kranzler HR; Aubin HJ; O'Malley SS; Mann K; Aldridge A; Hoffman M; Anton RF; Witkiewitz K
    Alcohol Alcohol; 2024 Mar; 59(3):. PubMed ID: 38606931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 5-year follow-up of depressed and bipolar patients with alcohol use disorder in an Irish population.
    Farren CK; Murphy P; McElroy S
    Alcohol Clin Exp Res; 2014 Apr; 38(4):1049-58. PubMed ID: 24428168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drinking Risk Level Reductions Associated with Improvements in Physical Health and Quality of Life Among Individuals with Alcohol Use Disorder.
    Witkiewitz K; Kranzler HR; Hallgren KA; O'Malley SS; Falk DE; Litten RZ; Hasin DS; Mann KF; Anton RF
    Alcohol Clin Exp Res; 2018 Dec; 42(12):2453-2465. PubMed ID: 30395350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Initial Pilot Testing of a fully integrated treatment for comorbid social anxiety disorder and alcohol use disorder in a community-based SUD clinic setting.
    Wolitzky-Taylor K; Sewart A; Karno M; Ries R; Stimson J
    Behav Res Ther; 2022 Jan; 148():103999. PubMed ID: 34813986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are non-abstinent reductions in World Health Organization drinking risk level a valid treatment target for alcohol use disorders in adolescents with ADHD?
    Mitchell HM; Park G; Hammond CJ
    Addict Behav Rep; 2020 Dec; 12():100312. PubMed ID: 33364320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttreatment Low-Risk Drinking as a Predictor of Future Drinking and Problem Outcomes Among Individuals with Alcohol Use Disorders: A 9-Year Follow-Up.
    Kline-Simon AH; Litten RZ; Weisner CM; Falk DE
    Alcohol Clin Exp Res; 2017 Mar; 41(3):653-658. PubMed ID: 28072453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized clinical trial of matching client alcohol use disorder severity and level of cognitive functioning to treatment setting: A partial replication and extension.
    Rychtarik RG; McGillicuddy NB; Papandonatos GD; Whitney RB; Connors GJ
    Psychol Addict Behav; 2017 Aug; 31(5):513-523. PubMed ID: 28150955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reductions in World Health Organization Risk Drinking Level Are Associated With Reductions in Alcohol Use Disorder Diagnosis and Criteria: Evidence From an Alcohol Pharmacotherapy Trial.
    Richards DK; Tuchman FR; Hallgren KA; Kranzler HR; Aubin HJ; O'Malley SS; Mann K; Aldridge A; Anton RF; Witkiewitz K
    J Addict Med; 2024 Jul-Aug 01; 18(4):418-424. PubMed ID: 38606854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Learning to resist the urge: a double-blind, randomized controlled trial investigating alcohol-specific inhibition training in abstinent patients with alcohol use disorder.
    Tschuemperlin RM; Stein M; Batschelet HM; Moggi F; Soravia LM
    Trials; 2019 Jul; 20(1):402. PubMed ID: 31277683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reductions in Drinking Predict Increased Distress: Between- and Within-Person Associations between Alcohol Use and Psychological Distress During and Following Treatment.
    Levine JA; Gius BK; Boghdadi G; Connors GJ; Maisto SA; Schlauch RC
    Alcohol Clin Exp Res; 2020 Nov; 44(11):2326-2335. PubMed ID: 32945567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Australian guidelines for the treatment of alcohol problems: an overview of recommendations.
    Haber PS; Riordan BC; Winter DT; Barrett L; Saunders J; Hides L; Gullo M; Manning V; Day CA; Bonomo Y; Burns L; Assan R; Curry K; Mooney-Somers J; Demirkol A; Monds L; McDonough M; Baillie AJ; Clark P; Ritter A; Quinn C; Cunningham J; Lintzeris N; Rombouts S; Savic M; Norman A; Reid S; Hutchinson D; Zheng C; Iese Y; Black N; Draper B; Ridley N; Gowing L; Stapinski L; Taye B; Lancaster K; Stjepanović D; Kay-Lambkin F; Jamshidi N; Lubman D; Pastor A; White N; Wilson S; Jaworski AL; Memedovic S; Logge W; Mills K; Seear K; Freeburn B; Lea T; Withall A; Marel C; Boffa J; Roxburgh A; Purcell-Khodr G; Doyle M; Conigrave K; Teesson M; Butler K; Connor J; Morley KC
    Med J Aust; 2021 Oct; 215 Suppl 7():S3-S32. PubMed ID: 34601742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.